
About our company
MSD Australia is more than just medicines, we invent for a more hopeful future.
We aspire to be the premier research-intensive biopharmaceutical company in the world
For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a sustainable and healthy future for all people and communities.

Environmental, Social & Governance (ESG)
Find out how we’re supporting the future of our business and the well-being of patients, people and communities around the world.

The team that guides our work
Our leaders focus on our mission to save and improve lives around the world. This is the foundation of everything we do.
Our company by the numbers
employees globally in 2022
Culture & valuesresearch and development investment in 2022 across the globe
Our research
Our values are driven by a desire to improve life
We’ve built a culture that embraces scientific excellence, operates with the highest standards of integrity, expands access to our products and employs a diverse workforce that values collaboration.

MSD Animal Health
MSD Animal Health is a research-driven company that develops, manufactures and markets a broad range of veterinary medicines and services.
We offer one of the industry’s most innovative portfolios, spanning products for the prevention, treatment and control of disease in all major farm and companion animal species.
Business partnerships and public policies keep our patients in focus

Business development & licensing
We work with partners, from early-stage science to clinical-stage programs, to deliver new therapies to patients.

Policies & positions
We support public policies that advance the interests of patients, improve public health and promote access to medicines and innovation.
AU-NON-00720 Last updated July 2023